The tyrosine kinase Lck is involved in regulation of mitochondrial apoptosis pathways

被引:30
作者
Belka, C
Gruber, C
Jendrossek, V
Wesselborg, S
Budach, W
机构
[1] Univ Tubingen, Dept Radiat Oncol, D-72076 Tubingen, Germany
[2] Univ Tubingen, Dept Internal Med 1, D-72076 Tubingen, Germany
关键词
D O I
10.1038/sj.onc.1206103
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The induction of apoptosis requires the activation of a highly coordinated signaling network ultimately leading to the activation of caspases. In previous experiments we and others have shown that the tyrosine kinase Lck is required for adequate apoptosis induction in response to ionizing radiation, ceramide incubation and overexpression of the HIV-TAT protein. However, the position of Lck within given apoptotic signaling cascades remains unclear. We therefore aimed to define the role of Lck during radiation-induced apoptosis. Apoptosis induction in response to ionizing radiation, CD95 or TRAIL receptor stimulation was determined in Jurkat T-cells, the Lck-deficient Jurkat clone JCaM1.6- and Lck-retransfected JCaM1.6/Lck. No apoptosis, release of cytochrome c, breakdown of the mitochondrial potential were detectable during the first 48 h after irradiation of JCaM1.6 cells. In parallel, no activation of caspase-9, -8 and -3 was detectable. Since mitochondrial apoptosis pathways act within a feedback mechanism during death-receptor-mediated apoptosis, the influence of the Lck defect on CD95/Fas/Apo-1-L or TRAIL-induced apoptosis was also tested. Both stimuli induced apoptosis in Lck-deficient cells. However, the kinetics of apoptosis induction determined by caspase-8, -9 and -3 activation as well as DeltaPsi(m) breakdown was slowed. We conclude that the Lck deficiency influences early steps during radiation-induced mitochondrial alterations.
引用
收藏
页码:176 / 185
页数:10
相关论文
共 50 条
[1]  
Belka C, 2000, ANTICANCER RES, V20, P3243
[2]   Radiation-induced apoptosis in human lymphocytes and lymphoma cells critically relies on the up-regulation of CD95/Fas/APO-1 ligand [J].
Belka, C ;
Marini, P ;
Budach, W ;
Schulze-Osthoff, K ;
Lang, F ;
Gulbins, E ;
Bamberg, M .
RADIATION RESEARCH, 1998, 149 (06) :588-595
[3]   Anti-apoptotic Bcl-2 proteins: structure, function and relevance for radiation biology [J].
Belka, C ;
Budach, W .
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2002, 78 (08) :643-658
[4]   The tyrosine kinase Lck is required for CD95-independent caspase-8 activation and apoptosis in response to ionizing radiation [J].
Belka, C ;
Marini, P ;
Lepple-Wienhues, A ;
Budach, W ;
Jekle, A ;
Los, M ;
Lang, F ;
Schulze-Osthoff, K ;
Gulbins, E ;
Bamberg, M .
ONCOGENE, 1999, 18 (35) :4983-4992
[5]   Sensitization of resistant lymphoma cells to irradiation-induced apoptosis by the death ligand TRAIL [J].
Belka, C ;
Schmid, B ;
Marini, P ;
Durand, E ;
Rudner, J ;
Faltin, H ;
Bamberg, M ;
Schulze-Osthoff, K ;
Budach, W .
ONCOGENE, 2001, 20 (17) :2190-2196
[6]   Differential role of caspase-8 and BID activation during radiation- and CD95-induced apoptosis [J].
Belka, C ;
Rudner, J ;
Wesselborg, S ;
Stepczynska, A ;
Marini, P ;
Lepple-Wienhues, A ;
Faltin, H ;
Bamberg, M ;
Budach, W ;
Schulze-Osthoff, K .
ONCOGENE, 2000, 19 (09) :1181-1190
[7]   The role of ceramide in receptor- and stress-induced apoptosis studied in acidic ceramidase-deficient Farber disease cells [J].
Burek, C ;
Roth, J ;
Koch, HG ;
Harzer, K ;
Los, M ;
Schulze-Osthoff, K .
ONCOGENE, 2001, 20 (45) :6493-6502
[8]   BCL-2, BCL-XL sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis [J].
Cheng, EHYA ;
Wei, MC ;
Weiler, S ;
Flavell, RA ;
Mak, TW ;
Lindsten, T ;
Korsmeyer, SJ .
MOLECULAR CELL, 2001, 8 (03) :705-711
[9]   Regulation of the Lck SH2 domain by tyrosine phosphorylation [J].
Couture, C ;
Zhou, SY ;
Jascur, T ;
Williams, S ;
Tailor, P ;
Cantley, LC ;
Mustelin, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (40) :24880-24884
[10]   Ultraviolet light-induced DNA damage triggers apoptosis in nucleotide excision repair-deficient cells via Bcl-2 decline and caspase-3/-8 activation [J].
Dunkern, TR ;
Fritz, G ;
Kaina, B .
ONCOGENE, 2001, 20 (42) :6026-6038